Adult Acute Lymphoblastic Leukemia Treatment (PDQ®): Treatment - Patient Information [NCI] - To Learn More About Adult Acute Lymphoblastic Leukemia
For more information from the National Cancer Institute about adult acute lymphoblastic leukemia,see the following: Leukemia Home Page What You Need to Know About™ Leukemia Understanding Cancer Series: Blood Stem Cell Transplants Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers For general cancer information and other resources from the National ...
Cancer Genetics Risk Assessment and Counseling (PDQ®): Genetics - Health Professional Information [NCI] - nci_ncicdr0000062865-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Cancer Genetics Risk Assessment and Counseling
PC-SPES (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - About PDQ
PDQ is a comprehensive cancer database available on NCI's Web site.PDQ is the National Cancer Institute's (NCI's) comprehensive cancer information database. Most of the information contained in PDQ is available online at NCI's Web site. PDQ is provided as a service of the NCI. The NCI is part of the National Institutes of Health, the federal government's focal point for biomedical research.PDQ contains cancer information summaries.The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries are available in two versions. The health professional versions provide detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions provide current and accurate cancer information. Images in the PDQ summaries are used with permission of the author(s), artist, and/or publisher
Liver (Hepatocellular) Cancer Prevention (PDQ®): Prevention - Patient Information [NCI] - Questions or Comments About This Summary
If you have questions or comments about this summary,please send them to Cancer.gov through the Web site’s Contact Form. We can respond only to email messages written in English. ...
Transitional Care Planning (PDQ®): Supportive care - Patient Information [NCI] - Changes to This Summary (10 / 23 / 2012)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.Editorial changes were made to this summary.
Adrenocortical Carcinoma Treatment (PDQ®): Treatment - Patient Information [NCI] - Recurrent Adrenocortical Carcinoma
Recurrent adrenocortical carcinoma is cancer that has recurred (come back) after it has been treated. The cancer may come back in the adrenal cortex or in other parts of the body.
Testicular Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Get More Information From NCI
For more information,U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 9:00 a.m. to 4:30 p.m.
Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®): Treatment - Patient Information [NCI] - nci_ncicdr0000258195-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment
Pain (PDQ®): Supportive care - Health Professional Information [NCI] - Palliative Interventions
Radiation TherapyRadiation therapy (RT) has been established as an effective treatment for pain caused by bony metastases. Local, half-body, or whole-body RT enhances the effectiveness of analgesic drugs and other noninvasive therapies by directly affecting the cause of pain (i.e., reducing primary and metastatic tumor bulk).[Level of evidence: I] RT reduces pain and its interference with function among ambulatory cancer patients with symptomatic bone metastases.External-beam radiation for bone metastasesExternal-beam radiation therapy (EBRT) produces significant reduction in bone pain in 50% to 80% of patients, with complete pain relief in 30% to 50% of patients. Dose fractionation schedules utilized for painful bone metastases vary considerably. Common fractionation schemes include 30 Gy in ten fractions, 24 Gy in six fractions, 20 Gy in five fractions, and 8 Gy in one fraction. Single- or multiple-fraction regimens of EBRT are equally effective when RT is administered
Antineoplastons (PDQ®): Complementary and alternative medicine - Health Professional Information [NCI] - Overview
This complementary and alternative medicine (CAM) information summary provides an overview of the use of antineoplastons as treatments for patients with cancer. The summary includes a brief history of the development of antineoplastons; a review of laboratory,animal,and human studies; and possible side effects associated with antineoplaston use. This summary contains the following key ...